EMPAZYE Trademark

Trademark Overview

On Thursday, June 13, 2019, a trademark application was filed for EMPAZYE with the United States Patent and Trademark Office. The USPTO has given the EMPAZYE trademark a serial number of 79263827. The federal status of this trademark filing is REGISTERED as of Tuesday, March 17, 2020. This trademark is owned by UCB Biopharma SPRL. The EMPAZYE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of neurology and immunology diseases
empazye

General Information

Serial Number79263827
Word MarkEMPAZYE
Filing DateThursday, June 13, 2019
Status700 - REGISTERED
Status DateTuesday, March 17, 2020
Registration Number6010435
Registration DateTuesday, March 17, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 31, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of neurology and immunology diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 30, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameUCB Biopharma SPRL
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBE
Party NameUCB Biopharma SPRL
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBE
Party NameUCB Biopharma SPRL
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBE

Trademark Events

Event DateEvent Description
Monday, November 9, 2020CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Friday, August 14, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, August 14, 2020CORRECTION TRANSACTION RECEIVED FROM IB
Monday, July 27, 2020FINAL DISPOSITION NOTICE SENT TO IB
Monday, July 27, 2020FINAL DISPOSITION PROCESSED
Wednesday, June 17, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, April 23, 2020CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, March 17, 2020REGISTERED-PRINCIPAL REGISTER
Saturday, January 4, 2020NOTIFICATION PROCESSED BY IB
Tuesday, December 31, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 31, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 18, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 18, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 11, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 27, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 12, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 12, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 12, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, October 19, 2019REFUSAL PROCESSED BY IB
Saturday, September 28, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, September 28, 2019REFUSAL PROCESSED BY MPU
Wednesday, September 18, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, September 17, 2019NON-FINAL ACTION WRITTEN
Monday, September 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 4, 2019ASSIGNED TO EXAMINER
Saturday, August 3, 2019APPLICATION FILING RECEIPT MAILED
Tuesday, July 30, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 25, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

empazye immunology diseases neurology treatment preparations substances pharmaceutical